Tonix Pharmaceuticals Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD

August 20, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search